{
   "title": "Celgene 's top product revenues 2013 to 2018",
   "labels": [
      "Product Name",
      "2013",
      "2014",
      "2015",
      "2016",
      "2017",
      "2018"
   ],
   "columnType": "multi",
   "graphType": "bar",
   "summary": [
      "This statistic shows the average number of weeks revenues Otezla_(psoriasis) and 's salon 2018 for females in the United Kingdom in 2013 , 2014 2015 and 2018 by type . ",
      "In 2013 , the time revenues Other averaged 0 weeks for women . ",
      "As of the 2014 survey , this has increased to 0 weeks ."
   ],
   "trends": [
      {
         "9": [
            "2",
            "0"
         ]
      },
      {
         "6": [
            "4",
            "0"
         ],
         "8": [
            "4",
            "1"
         ]
      },
      {
         "10": [
            "4",
            "2"
         ]
      }
   ],
   "data": [
      {
         "Product Name": "Revlimid (cancer)",
         "2013": "4280.3",
         "2014": "4980",
         "2015": "5801.1",
         "2016": "6973.6",
         "2017": "8187",
         "2018": "9685"
      },
      {
         "Product Name": "Pomalyst/Imnovid (cancer)",
         "2013": "305.4",
         "2014": "679.7",
         "2015": "983.3",
         "2016": "1310.7",
         "2017": "1614",
         "2018": "2040"
      },
      {
         "Product Name": "Otezla (psoriasis)",
         "2013": "0",
         "2014": "69.8",
         "2015": "471.7",
         "2016": "1017.2",
         "2017": "1279",
         "2018": "1608"
      },
      {
         "Product Name": "Abraxane (cancer)",
         "2013": "648.9",
         "2014": "848.2",
         "2015": "967.5",
         "2016": "973.4",
         "2017": "992",
         "2018": "1062"
      },
      {
         "Product Name": "Other",
         "2013": "0",
         "2014": "0",
         "2015": "0",
         "2016": "0",
         "2017": "901",
         "2018": "870"
      }
   ],
   "gold": "This statistic reveals the revenues generated by biotech company Celgene 's top products between 2013 and 2018 . In 2014 , one of the company 's top products , Otezla , generated revenues of around 70 million U.S. dollars . Otezla 's annual revenue increased up to 1.6 billion dollars until 2018 .\n"
}